Through their functional diversification, distinct lineages of CD4 1 T cells can act to either drive or constrain immune-mediated pathology. Transcription factors are critical in the generation of cellular diversity, and negative regulators antagonistic to alternate fates often act in conjunction with positive regulators to stabilize lineage commitment 1 . Genetic polymorphisms within a single locus encoding the transcription factor BACH2 are associated with numerous autoimmune and allergic diseases including asthma 2 , Crohn's disease 3, 4 , coeliac disease 5 , vitiligo 6 , multiple sclerosis 7 and type 1 diabetes 8 . Although these associations point to a shared mechanism underlying susceptibility to diverse immune-mediated diseases, a function for BACH2 in the maintenance of immune homeostasis has not been established. Here, by studying mice in which the Bach2 gene is disrupted, we define BACH2 as a broad regulator of immune activation that stabilizes immunoregulatory capacity while repressing the differentiation programs of multiple effector lineages in CD4 1 T cells. BACH2 was required for efficient formation of regulatory (T reg ) cells and consequently for suppression of lethal inflammation in a manner that was T reg -cell-dependent. Assessment of the genome-wide function of BACH2, however, revealed that it represses genes associated with effector cell differentiation. Consequently, its absence during T reg polarization resulted in inappropriate diversion to effector lineages. In addition, BACH2 constrained full effector differentiation within T H 1, T H 2 and T H 17 cell lineages. These findings identify BACH2 as a key regulator of CD4 1 T-cell differentiation that prevents inflammatory disease by controlling the balance between tolerance and immunity.
BACH2 is expressed in B cells where it acts as a transcriptional repressor of Blimp-1 (also known as PR domain zinc finger 1) and is critical for somatic hypermutation and class switch recombination [9] [10] [11] . Given the association of polymorphisms in the BACH2 locus with multiple inflammatory diseases in humans, however, we proposed a role for the transcription factor in the prevention of inflammation. To test this hypothesis, we characterized the phenotype of knockout (KO) mice in which the Bach2 gene had been disrupted 9 . Although pups appeared normal at birth, they developed a progressive wasting disease ( Fig. 1a and Supplementary Fig. 1a ) that resulted in diminished survival compared to wild-type (WT) littermates ( Fig. 1b) . Sera from KO mice at 3 months of age contained elevated levels of anti-nuclear and anti-double stranded DNA autoantibodies (Fig. 1c ). Gross examination revealed enlargement of the lungs ( Fig. 1d and Supplementary  Fig. 1b ) with highly penetrant histopathological changes ( Fig. 1e ), including extensive perivascular and alveolar infiltration by lymphocytes and macrophages (Fig. 1f ). Examination of the gut revealed less severe and incompletely penetrant inflammatory pathology of the small intestine and stomach also associated with lymphocytic and macrophage infiltration ( Fig. 1g and Supplementary Fig. 2 ). Consistently, we measured elevated expression of the C-C chemokine receptors CCR4 and CCR9 on splenic CD4 1 T cells that guide migration to the lung and gut, respectively ( Fig. 1h) 12, 13 . Accordingly, we found a striking increase in the number of CD4 1 T cells in the lungs of KO animals, whereas peripheral lymphoid organs contained similar or decreased numbers ( Fig. 1i and Supplementary Fig. 3 ). We also observed increased proportions of effector cells in both the spleen and lungs of KO animals (Supplementary Fig. 4a ) and a substantial proportion of CD4 1 T cells in the lungs expressed the acute activation marker CD69 ( Fig. 1j and Supplementary Fig. 4b ), a finding indicative of their involvement in the inflammatory process affecting this organ.
CD4 1 T cells can be characterized into a number of functionally specialized subsets depending upon expression of lineage-specific transcription factors and cytokines 14 . T H 2 cells have a central role in allergic inflammation and airway disease and are characterized by expression of the transcription factor GATA3 and cytokines such as interleukin (IL)-4 and IL- 13 (ref. 15) . Consistent with the presence of T H 2 inflammation, there were increased proportions of GATA3 1 CD4 1 T cells in the spleen and lungs ( Fig. 1k and Supplementary  Fig. 5 ) and elevated expression of IL-13 and IL-4 in the spleen, lungs and lymph nodes of KO animals ( Fig. 1l and Supplementary Fig. 6a ). By contrast, we observed no differences in the frequency of IL-17A 1 cells in these organs and only a minor increase in interferon (IFN)-c 1 cells in the lymph nodes ( Supplementary Fig. 6b ).
CD4 1 T cells can function to both drive and constrain immunemediated pathology. Whereas effector (T eff ) cells are often implicated in immune-mediated disease, FOXP3 1 T reg cells suppress inflammatory reactions and have a non-redundant role in maintaining immune homeostasis 16, 17 . Given dysregulated immune reactions in Bach2deficient animals, we measured the expression of Bach2 messenger RNA (mRNA) in conventional and regulatory CD4 1 T-cell subsets and their thymic precursors from Foxp3 GFP reporter mice, which express GFP under the control of the endogenous Foxp3 promoter. Bach2 mRNA was expressed at high levels in both conventional FOXP3and FOXP3 1 (T reg ) CD4SP thymocytes in addition to naive (T nai ) and T reg cells in the spleen ( Fig. 2a ).
Evaluation of conventional thymic maturation in KO animals revealed similar proportions of CD4SP, CD8SP and TCRb 1 cells ( Supplementary Fig. 7 ). Given high levels of expression of Bach2 mRNA in CD4SP thymocytes, however, we wished to determine the cell-intrinsic function of BACH2 in regulating gene transcription within these cells. We reconstituted Rag1 -/hosts with equal mixtures of lineage-depleted bone marrow cells (hereafter BM) from congenically distinguishable Ly5.1 1 WT and Ly5.1 -KO animals and measured global gene expression in WT and KO CD4SP cells that had developed within the same host ( Supplementary Fig. 8 18 . Consistent with these observations, Foxp3 mRNA itself showed the greatest fold-reduction in expression amongst all transcripts measured ( Fig. 2b and Supplementary Fig. 9b ). Consequently, we observed a near complete absence of FOXP3 1 cells amongst KO CD4SP thymocytes in WT:KO mixed BM chimaeric animals ( Fig. 2c and Supplementary Fig. 10 ). In animals reconstituted with either KO BM alone ( Fig. 2c ) or equal mixtures of KO and FoxP3 sf BM ( Supplementary Fig. 11 ), however, FOXP3 1 KO cells were present in both the thymus and spleen but at a lower frequency than when WT cells were transferred. Taken together, these findings indicated a cellautonomous requirement for BACH2 in the formation of T reg cells in the thymus with an incomplete defect in non-competitive environments.
Whereas a proportion of T reg cells found in peripheral tissues arise in the thymus (thymic T reg or tT reg ) 16 , induced T reg (iT reg ) cells develop from conventional FOXP3 -CD4 1 T cells in extrathymic tissues. To test whether BACH2 was required for efficient formation of iT reg cells, we tracked the fate of naive CD4 1 T cells upon transfer into Rag1 -/hosts. Although a proportion of WT CD4 1 T cells converted into FOXP3 1 iT reg cells, significantly fewer KO cells underwent similar conversion ( Supplementary Fig. 12 ). By contrast, KO cells showed similar stability of FOXP3 expression and survival upon transfer into Rag1 -/hosts over acute time points ( Supplementary Fig. 13 ). Consistent with in vivo data, KO naive CD4 1 T cells were markedly impaired in their ability to induce Foxp3 mRNA and form FOXP3 1 iT reg cells upon stimulation in the presence of TGF-b in vitro ( Fig. 2d , Supplementary Fig. 14) . Despite this, KO cells exhibited intact TGF-b and IL-2 signalling ( Supplementary Fig. 15 ). Importantly, defective iT reg induction in KO cells was rescued by reconstitution with Bach2-expressing retroviruses ( Fig. 2e ), confirming that BACH2 is required during induction for the formation of iT reg cells. In addition, Bach2 overexpression in WT cells enhanced FOXP3 induction under suboptimal polarizing conditions ( Supplementary Fig. 16 ).
Taken together, our results demonstrated a requirement for BACH2 in the efficient generation of both tT reg and iT reg cells. Accordingly, 
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analysis of primary and secondary lymphatic tissues from KO mice at 3 months of age revealed a deficiency in T reg cells resembling that in mice individually reconstituted with KO BM (Fig. 2f ). Similar reduction in thymic T reg cell frequency was observed in neonatal mice before evidence of autoimmune disease ( Supplementary Fig. 17 ). Furthermore, T reg cell formation was Bach2 gene-dose dependent because mice heterozygous for the KO allele had reduced frequencies of T reg cells ( Supplementary Fig. 18 ). Thus, T reg cells are found at low frequencies in KO mice despite the presence of inflammation in these animals. Characterization of these cells revealed higher levels of expression of T reg cell suppressive molecules CD25, CTLA4 and GITR (also known as TNFRSF18), the activation marker CD69 and the marker of terminal differentiation, KLRG1 ( Fig. 2g and Supplementary Fig. 19 ; P , 0.05) 19 . Consistent with this terminally differentiated phenotype, T reg cells from Bach2-deficient mice failed to prevent colitis in long-term assays despite possessing acute suppressive function ( Supplementary Fig. 20a -e) 19 . Because T reg cells maintain immune homeostasis in an immunodominant fashion, disorders resulting from their deficiency are amenable to rescue by provision of wild-type T reg cells. To test whether failure to maintain immune homeostasis in the absence of BACH2 was a consequence of defective immunoregulatory capacity, we reconstituted lethally irradiated Rag1 -/mice with KO BM in the presence or absence of WT BM. Strikingly, although we observed massive induction of effector differentiation amongst KO CD4 1 T cells and mucosal thickening of the large intestine accompanied by infiltration of KO cells when KO BM was transferred independently, these changes were prevented by co-transfer of WT BM (Fig. 3a, b and Supplementary Fig. 21a ). Consequently, animals reconstituted with KO BM showed profound weight loss and diminished survival whereas cotransfer of WT BM prevented the induction of disease (Supplementary Fig. 21b, c) . The dominant immunoregulatory effect exerted by Bach2-sufficient (WT) BM was dependent upon FOXP3 because BM from mice which possess an intact Bach2 locus but lack functional FOXP3 protein (Foxp3 sf ) 20 could not rescue the phenotype induced by KO BM (Fig. 3c) . Moreover, the lethal phenotype induced by KO BM was rescued by transfer of purified splenic CD4 1 CD25 1 T reg cells from WT mice. Thus, BACH2 is required for the prevention of lethal autoimmunity through its role in T reg cell formation.
Taken together, these results demonstrated a non-redundant role for BACH2 in T reg -mediated immune homeostasis. For transcriptional repression, BACH2 is dependent upon a DNA-binding basic leucine zipper region located near the carboxy terminus of the protein 21 . 
RESEARCH LETTER
We found that overexpression of a truncation mutant deficient in this region (Bach2 DZip ) did not complement defective iT reg induction in KO CD4 1 T cells (Fig. 4a ), implicating its function as a transcriptional regulator in T reg cell formation. To identify genes whose expression is controlled by BACH2, we performed massively parallel RNA sequencing of KO naive CD4 1 T cells stimulated under iTreg polarizing conditions. Consistent with its role as a transcriptional repressor, a majority of differentially expressed genes were upregulated in Bach2-deficient cells ( Supplementary Fig. 22 ). Strikingly, when we compared these genes with transcripts that were induced upon differentiation of naive cells into effector-lineage T H 1, T H 2 or T H 17 cells, we found that 31.8% (877) of all upregulated genes (2, 754) in Bach2-deficient cells were effector-lineage-associated genes (Fig. 4b, c) . To test whether BACH2 has a direct role in mediating these transcriptional differences, we measured genome-wide BACH2 binding in iT reg cells by chromatin immunoprecipitation with massively parallel sequencing (ChIP-Seq), validating selected loci by quantitative PCR ( Supplementary Fig. 23 and Supplementary Table 7 ). Remarkably, BACH2 bound 43.6% of all derepressed genes, including 408 derepressed effector lineage-associated genes (Fig. 4b, c ). Examples from this group of genes are provided ( Fig. 4d and Supplementary  Fig. 24a ), notably, BACH2 bound and repressed Prdm1, which encodes Blimp-1, a transcription factor critical in driving full effector differentiation in CD4 1 T cells 22 . BACH2 also repressed genes with effector-lineage-specific functions such as Gata3, Irf4 and Nfil3, and Il12rb1, Il12rb2, Map3k8 and Gadd45g, which have important roles in T H 2 and T H 1 differentiation, respectively [23] [24] [25] [26] [27] . Additionally, BACH2 repressed Ahr, which is involved in T h 17 differentiation 28 . Importantly, a number of effector-lineage-associated genes repressed by BACH2 encode proteins that transduce signals antagonistic to T reg cell differentiation itself, including Il12rb1, Il12rb2 and Tnfsf4 29, 30 . Repression of Ccr4 and Ccr9 by BACH2 ( Supplementary Fig. 24b ) was also of interest since it provides some explanation for the predominance of lung and gut immunopathology in KO animals.
These data indicated that an important aspect of the function of BACH2 is to repress the differentiation programs of multiple effector lineages during iT reg cell development. Accordingly, KO CD4 1 T cells stimulated under iT reg conditions aberrantly expressed cytokines associated with effector lineages (Fig. 4e ). To test whether BACH2 stabilizes iT reg cell development through repression of effector differentiation, we examined whether blockade of effector cytokines, which play an important role in positive reinforcement of effector cell differentiation, could restore iT reg induction in KO cells. Whereas KO cells stimulated under iT reg conditions preferentially differentiated into FOXP3cells expressing T-bet, GATA3 or RORct, master regulators of the T H 1, T H 2 and T H 17 differentiation programs, respectively ( Fig. 4f ), addition of neutralizing antibodies against IFN-c and IL-4 partially reverted this phenotype, preventing aberrant induction of 
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T-bet and GATA3 and restoring FOXP3 expression. Interestingly, RORct expression in KO cells increased in the presence of anti-IFNc and anti-IL-4 antibodies, consistent with the recognized ability of IFN-c and IL-4 to block T h 17 differentiation. Consequently, higher levels of IL-17A were expressed by KO cells under these conditions ( Supplementary Fig. 25 ). These observations raised the possibility that BACH2 might also constrain full effector differentiation amongst conventional T-cell subsets. Strikingly, and consistent with this hypothesis, we observed increased IFN-c, IL-13 and IL-17A expression when KO naive CD4 1 cells were stimulated under T H 1, T H 2 and T H 17 conditions, respectively. Thus, additional to its role in T reg cell development, BACH2 limits full effector differentiation in conventional CD4 1 T cells (Fig. 4g) . During specification of a variety of tissues, negative regulators antagonistic to alternative fates often act in conjunction with positive regulators to stabilize lineage identity 1 . We have identified a function of BACH2 in repressing the differentiation programs of multiple effector lineages in CD4 1 T cells. By doing so, BACH2 stabilizes the development of T reg cells while limiting full effector differentiation in conventional T cell lineages. Thus, at both a cellular and molecular level, BACH2 functions to constrain immune activation, enabling it to play a critical role in the maintenance of immune homeostasis. These findings help explain the emergence of BACH2 as a key node in human autoimmunity.
METHODS SUMMARY
Experiments were approved by the Institutional Animal Care and Use Committees of the NCI and NIAMS and performed in accordance with NIH guidelines. C57BL/ 6J, Rag1 -/-(B6.129S7-Rag1 tm1Mom/J ), Ly5.1 1/1 (B6.SJL-Ptprc a Pepc b /BoyJ) and Foxp3 GFP (B6.Cg-Foxp3 tm2Tch /J) mice were purchased from The Jackson Laboratory. Bach2 KO mice, which have been previously described 9 , were backcrossed .16 times with C57BL/6 mice.
METHODS
Mice. Experiments were approved by the Institutional Animal Care and Use Committees of the NCI and NIAMS and performed in accordance with NIH guidelines. C57BL/6J, Rag1 -/-(B6.129S7-Rag1 tm1Mom/J ), Ly5.1 1/1 (B6.SJL-Ptprc a Pepc b /BoyJ) and Foxp3 GFP (B6.Cg-Foxp3 tm2Tch /J) mice were purchased from The Jackson Laboratory. Bach2 KO mice, which have been previously described 9 , were backcrossed .16 times with C57BL/6 mice. Plasmid DNA and cloning. For the generation of pMSCV-IRES-Bach2-Thy1.1, a fragment of Bach2 cDNA was amplified by PCR from pMSCV-IRES-Bach2-EGFP 1 using the following primers: forward, 59-GTATTAGCGGCCGCAGACC ATGGACTACAAGGACGACGATGACAAG-39 and reverse, 59-GATGAAATC GATCTAGGCATAATCTTTCCTGGGCTGTTCGTCCG-39 and cloned between the NotI and ClaI sites within the multiple cloning site of pMSCV-IRES-Thy1.1-DEST (pMIT; Addgene 17442). pMIG-Bach2 and pMIG-Bach2 DZip have been described previously 10 . Cell culture. CD4 1 T cells from spleens and lymph nodes of 6-8-week-old mice were purified by negative magnetic selection (Miltenyi) followed by sorting of naive CD4 1 CD62L high CD44 2 CD25 2 cells using a FACSAria II sorter (BD). For isolation of T reg cells, CD4 1 GFP 1 cells were sorted from Foxp3 GFP reporter mice or CD4 1 CD25 high cells were sorted from WT mice. Naive CD4 1 T cells were activated with plate-bound anti-CD3 and soluble anti-CD28 (10 mg ml 21 each; eBioscience) in media for 3 days either under: Th0 conditions (media alone); Th1 conditions (IL-12 (20 ng ml 21 , R&D Systems) and anti-IL-4 neutralizing antibodies (10 mg ml 21 , BioXCell)); T H 2 conditions (IL-4 (20 ng ml 21 , R&D Systems) and anti-IFN-c neutralizing antibodies (10 mg ml 21 , BD Pharmingen)); Th17 conditions (IL-6 (20 ng ml 21 , R&D Systems), human TGF-b1 (2 ng ml 21 , R&D Systems), anti-IFN-c neutralizing antibodies (10 mg ml 21 ) and anti-IL-4 neutralizing antibodies (10 mg ml 21 )) or iTreg conditions (IL-2 (100 IU ml 21 , R&D Systems) and human TGF-b1 (5 ng ml 21 )). Where indicated, purified naive CD4 1 T cells were labelled with carboxyfluorescein succinimidyl ester (CFSE, 1 mM, Molecular Probes) for 8 min at room temperature. The labelling reaction was quenched by washing in FCS. Retroviral transduction. 20 mg of retroviral plasmid DNA along with 6 mg pCL-Eco plasmid DNA were transfected using 60 ml Lipofectamine 2000 in 3 ml OptiMEM (Invitrogen) for 8 h in antibiotic-free media into Platinum-E ecotropic packaging cells (Cell Biolabs) plated a day prior on poly-D-lysine-coated 10-cm plates (Becton Dickinson) at a concentration of 6 3 10 6 cells per plate. Media were replaced 8 h after transfection and cells were incubated for a further 48 h. Retroviral supernatants were collected and spun at 2,000g for 2 h at 32 uC onto 24-well non-tissue culture treated plates coated overnight in Retronectin (20 mg ml 21 ; Takara Bio) and 5 mg ml 21 anti-CD3 (2C11) and 5 mg ml 21 anti-CD28 (37.51) (eBioscience). Supernatant was discarded and cells were applied to plates 1 day after stimulation in triplicate wells for 24 h in the presence of polarizing cytokines. Following transduction, cells were cultured on fresh anti-CD3 coated plates until analysis at day 5 post-stimulation. Antibodies and flow cytometry. The following fluorescent dye-conjugated antibodies against surface and intracellular antigens were used: anti-FOXP3 (FJK-16s), anti-IL-13 (eBio13A), anti-IL-17A clone eBio17B7 and anti-GATA3 clone TWAJ (eBioscience); anti-Thy1.1 (OX-7), anti-Ly5.1 (A20), anti-KLRG1 (2F1), anti-B220 (RA3-6B2), anti-NK1.1 (PK136), anti-CTLA4 (UC10-4F10-11), anti-CD4 (RM4-5), anti-CD25 (PC61), anti-CD62L (MEL-14), anti-IFN-c (Cat 554413), anti-IL-4 (Cat 554435), anti-CD44 (IM7) and anti-CD8a clone 53-6.7 (BD Biosciences); anti-GITR Cat. FAB5241A (R&D Systems) and anti-CD19 clone 6D5 (Biolegend). Cells were incubated with specific antibodies for 30 min on ice in the presence of 2.4G2 monoclonal antibody to block FccR binding. All samples were acquired with a Canto II flow cytometer (Becton Dickinson) and analysed using FlowJo software (TreeStar). Intranuclear staining for FOXP3 was carried out using the FOXP3 staining kit (eBioscience). To determine cytokine expression, cellular suspensions containing T cells were stimulated in media containing phorbol 12-myristate 13-acetate, ionomycin and brefeldin-A (Leukocyte activation cocktail with Golgiplug; BD biosciences) for 4 h. After stimulation, cells were stained an amine-reactive exclusion-based viability dye (Invitrogen) and with antibodies against cell-surface antigens, fixed and permeabilized followed by intracellular staining with specific anti-cytokine antibodies. Single-cell suspensions from lung tissues were prepared by mechanical disruption (GentleMACS, Miltenyi). Countbright beads were spiked-in for the flow cytometric quantification of absolute cell number (Invitrogen). Autoantibody enzyme-linked immunosorbent assay (ELISA). For measurement of antinuclear antibodies (ANAs), ELISA assays were performed on mouse serum according to manufacturer's instructions (Alpha Diagnostic International). For the measurement of anti-dsDNA autoantibodies, dsDNA-coated plates (Calbiotech) were incubated with serum samples and anti-dsDNA titres were evaluated using a horseradish peroxidase-conjugated anti-mouse antibody (IgG, IgM, IgA) (Alpha Diagnostic International). Quantitative reverse-transcription polymerase chain reaction (qRT-PCR). Cells were sorted or transferred into RNALater solution (Ambion) and stored at 280 uC. Total RNA from pelleted cells was isolated using the RNeasy Plus mini kit (Qiagen). First-strand cDNA synthesis was performed using random priming with the high-capacity cDNA synthesis kit (Applied Biosystems) in the presence of SuperaseIn RNase inhibitor (Ambion). cDNA was used as a template for quantitative PCR reactions using the following Taqman primer-probes (Applied Biosystems): Actb (mm00607939_s1), Bach2 (mm00464379_m1) and Foxp3 (mm00475162_m1). Reactions were performed using Fast Universal PCR Mastermix (Applied Biosystems) according to the manufacturer's instructions and thermocycled in quadruplicate 10 ml reactions in 384-well plates. Signals in the FAM channel were normalized to ROX intensity, and C t values were calculated using automatically determined threshold values using SDS software (Applied Biosystems). Bone marrow chimaeras and T reg cell rescue experiments. For bone marrow reconstitution experiments, Rag1 -/mice were administered 1,000 Gy total-body c-radiation from a 137 Cs source before intravenous injection of BM cells depleted of mature lineages from single-cell bone-marrow preparations using antibodycoupled magnetic beads (Miltenyi). Bone marrow from 6-10-week-old donor mice were used except with Scurfy mice where 12 day old pups were used as donors. Where indicated, 4 3 10 5 fluorescence-activated cell sorting (FACS)-purified CD4 1 CD25 1 T cells were transferred intravenously into mice 1 day after transfer of bone marrow cells. In vivo iT reg induction. Rag1 2/2 mice were injected intravenously with 4 3 10 5 CD4 1 CD25 2 CD45RB high cells from wild-type or Bach2-deficient mice. On day 21 to 23, cells were isolated and analysed for FOXP3 expression. In vitro suppression assay. Varying numbers of WT and KO CD4 1 CD25 1 T reg cells were cultured in 96-well round-bottom plates with 5 3 10 4 CFSE-labelled naive CD4 1 CD62L 1 CD44 low responder (T resp ) cells along with 1 3 10 4 CD11c 1 dendritic cells used as antigen-presenting cells, isolated by immunomagnetic selection (Miltenyi). Cells were stimulated with 1 mg ml 21 anti-CD3 antibody (BD Biosciences) for 72 h at 37 uC and 5% CO 2 . T resp cell proliferation was measured by flow cytometry. In vivo suppression assay. In vivo suppression assays were done as previously described 31 . Briefly, Rag2 2/2 mice were injected intravenously with 1 3 10 5 CFSElabelled naive CD4 1 CD25 2 CD45Rb hi (T resp ) cells from CD45.1 mice with or without 1 3 10 5 wild type or BACH2-deficient CD4 1 Foxp3 GFP1 T reg cells. Mice were analysed on day seven for T resp cell proliferation by flow cytometry. Transfer colitis model. The transfer colitis model has been described previously 32 . Briefly, Rag1 2/2 mice were injected intravenously with 4 3 10 5 FACS-sorted naive CD4 1 CD25 2 CD45RB high cells from CD45.1 1 mice with or without 1 3 10 5 WT or KO CD4 1 CD25 high T reg cells. Mice were monitored weekly for weight loss and signs of disease, and killed at week 6. Sections of the proximal, mid-, and distal colon were fixed in buffered 10% formalin and stained with haematoxylin and eosin (H&E). RNA sequencing. RNA sequencing was performed and analysed as described previously 33 . Total RNA was prepared from approximately 1 million cells by using mirVana miRNA Isolation Kit (AM1560, ABI). 200 ng of total RNA was subsequently used to prepare RNA-seq libraries by using TruSeq SRRNA sample prep kit (FC-122-1001, Illumina) according to the manufacturer's instructions. The libraries were sequenced for 50 cycles (single read) using a HiSeq 2000 sequencer (Illumina). Sequence reads from each cDNA library were mapped onto the mouse genome build mm9 by using Tophat, and the mappable data were then processed by Cufflinks 34 . The obtained data were normalized based on RPKM (reads per kilobase exon model per million mapped reads). To find differentially regulated genes, we used a 1.5-fold change difference between genotypes and a fourfold change difference between different lineages. Chromatin immunoprecipitation. T cells were chemically crosslinked and sonicated to generate fragmented genomic DNA. Chromatin immunoprecipitation was performed using an anti-BACH2 antibody (N-2; Tohoku University). For sequencing of immunoprecipitated DNA, DNA fragments were blunt-end ligated to the Illumina adaptors, amplified, and sequenced by using the Hi-Seq 2000 sequencer (Illumina). Sequence reads of 50 base pairs were obtained by using the Illumina Analysis Pipeline. All reads were mapped to the mouse genome (mm9), and only uniquely matching reads were retained. After removal of redundant reads, enriched peaks were called using ChIP-Seq analysis tool MACS 35 . Around 20,000 peaks were detected at a P-value level of less than 1 3 10 24 and false discovery rate of less than 5%. Peaks in 62 kb vicinity of gene bodies were assigned to genes to identify the bound target genes. For PCR-based confirmation of BACH2 binding, chromatin immunoprecipitation was performed as described above, and qPCR reactions were carried out on input and immunoprecipitated LETTER RESEARCH
